Ministry of Science and Technology: 4 new crown vaccines entered Clinical Phase III 60,000 people were vaccinated without serious adverse reactions.

Pharma Network October 21 - The Ministry of Science and Technology, Deputy Director of the Department of Social Development Science and Technology Tian Baoguo said on the 20th, four into phase III clinical trial stage of the new crown vaccine, overall progress is progressing smoothly, so far a total of about 60,000 subjects have been vaccinated, no serious adverse reactions reported.
State Council joint prevention and control mechanism held a press conference on the 20th to introduce the new crown vaccine related to the situation.
conference, Tian Baoguo introduced the progress of The Vaccine Phase III clinical trial.
is the most powerful technical tool for controlling infectious diseases, said Baoguo Tanaka.
Scientific research team for the first time to vaccine research and development as a top priority, layout of inactivated vaccine, recombinant protein vaccine, adenovirus vector vaccine and anti-virus virus vector vaccine and nucleic acid vaccine five technical routes in parallel research and development, the organization of the country's 12 advantages of the team to carry out joint research and development, in strict accordance with the requirements of relevant laws and regulations, in accordance with the procedures, do not lower standards, to ensure safety, under the premise of standardized and orderly research and development work.
said that at present, China's vaccine research and development work is generally in a leading position, each of our technical routes have entered the clinical research stage of the vaccine, specifically, 13 vaccines have entered clinical trials.
, four vaccines in the two technical routes of inactivated vaccine and adenovirus vector vaccine entered Phase III clinical trials.
four vaccines that have entered Phase III clinical trials are progressing well overall, with a total of about 60,000 subjects vaccinated so far and no reports of serious adverse reactions.
showed good security at first.
Tian Baoguo said that the results of Phase III clinical trials are an indicator to verify the internationally recognized effectiveness of vaccine protection, in the current situation of China's new crown epidemic has been effectively controlled, do not have the conditions to carry out Phase III clinical trials, how to select suitable regions and subjects, as well as the smooth organization and implementation of Phase III clinical trials, is currently the main problem facing phase III clinical trials.
next step, the research team will actively promote vaccine research and development in accordance with scientific laws and the principle of compliance with the law.
.